Required section · Section 5 of 6

Choose the Next Step and Write the Note

You are working the same case. The interference listing is clean, the clinical picture includes CKD G4, anemia, and ESA therapy, and the A1c-derived eAG runs well below both the home log and the same-day central-lab glucose. Before you write anything, decide what you are actually being asked to do: identify the most likely source of the discordance, choose the most informative next laboratory check, and draft a bounded interpretive note. You are not being asked to change a dose or set a new target.

The interpretive note itself has a shape. State what was measured and when. State what is discordant and by how much. State the most likely explanation given the method information and the clinical picture. Name the next check. Stop there. Anything about dose, target, or treatment plan is out of scope for a laboratory interpretive note and belongs to the ordering clinician, working within local policy.

A good interpretive note separates what the method measured from what the result may mean, and it ends at the next test, not at a treatment plan.

Ordering exercise

Put the guided case's investigation steps in the order that keeps the reasoning defensible, from first check to final note.

1. Compare A1c-derived eAG to glucose data

Line up the eAG (~137 mg/dL) against the home log mean and the same-day central-lab glucose (158 mg/dL).
2. Draft the interpretive note

State the observed discordance and the likely explanation in the chart, without recommending an insulin dose change.
3. Rule out assay interference

Confirm no known hemoglobin variant is flagged on the current interference listing for this analyzer.
4. Order the next informative check

Request fructosamine or glycated albumin, or review CGM/structured self-monitored-glucose data, since both are largely independent of red-cell lifespan.
5. Flag red-cell survival factors

Note CKD stage G4, anemia, and ESA therapy as conditions that shorten red-cell lifespan.

Knowledge checks

Reading and checks are open. Sign in only to save.

Knowledge check 1

In the guided case, the A1c-derived eAG (~137 mg/dL) is discordant with the home log mean and the same-day central-lab glucose (158 mg/dL), the interference listing shows no effect for this patient's phenotype, and the patient has CKD G4, anemia, and ESA therapy. What is the most informative next laboratory check?

Choose one option.

Fructosamine, glycated albumin, or a review of CGM/structured self-monitored-glucose data, since these are largely independent of red-cell lifespan.

Repeat the A1c on the same sample.

Order a hemoglobin electrophoresis regardless of the interference listing already showing no effect.

Increase the insulin dose based on the higher glucose readings.

Section status

Finish this section

Reading and checks are open. Sign in only to save.

The module finishes after every required section is marked done and every check in those sections is correct.